Home > Balance Sheet > EMCURE PHARMACEUTICALS

EMCURE PHARMACEUTICALS
Deferred Tax Assets / Liabilities

    Back to Balance Sheet
EMCURE PHARMACEUTICALS is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for EMCURE PHARMACEUTICALS
Please provide your vote to see the results

EMCURE PHARMACEUTICALS Last 5 Year Deferred Tax Assets / Liabilities History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
Deferred Tax Assets / Liabilities ₹-41 Cr₹9.04 Cr₹41 Cr₹-60 Cr₹-73 Cr

What is the latest Deferred Tax Assets / Liabilities ratio of EMCURE PHARMACEUTICALS ?

The latest Deferred Tax Assets / Liabilities ratio of EMCURE PHARMACEUTICALS is ₹-41 Cr based on Mar2026 Consolidated results.
Year Deferred Tax Assets / Liabilities
Mar2026₹-41 Cr
Mar2025₹9.04 Cr
Mar2024₹41 Cr
Mar2023₹-60 Cr
Mar2022₹-73 Cr

How is Deferred Tax Assets / Liabilities of EMCURE PHARMACEUTICALS Trending?

Years Deferred Tax Assets / Liabilities % Change
Mar2026 ₹-41 Cr
Negative
Mar2025 ₹9.04 Cr
-77.74
Mar2024 ₹41 Cr
Positive
Mar2023 ₹-60 Cr
Negative
Mar2022 ₹-73 Cr -

Compare Deferred Tax Assets / Liabilities of peers of EMCURE PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
EMCURE PHARMACEUTICALS ₹36,584.6 Cr 3.9% -0.4% 34.8% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹455,634.0 Cr -2.9% -2.3% 21.8% Stock Analytics
DIVIS LABORATORIES ₹241,576.0 Cr -1.6% 9.8% 51.8% Stock Analytics
TORRENT PHARMACEUTICALS ₹184,478.0 Cr -2.6% -2.3% 37.5% Stock Analytics
CIPLA ₹111,888.0 Cr -2.2% -6.1% -12.5% Stock Analytics
DR REDDYS LABORATORIES ₹96,322.1 Cr -0.9% -1.8% -9.8% Stock Analytics


EMCURE PHARMACEUTICALS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
EMCURE PHARMACEUTICALS

3.9%

-0.4%

34.8%

SENSEX

-1%

-2.6%

-4.1%


You may also like the below Video Courses